Rankings
▼
Calendar
BLTE Q2 2020 Earnings — Belite Bio, Inc Revenue & Financial Results | Market Cap Arena
BLTE
Belite Bio, Inc
$7B
Q2 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$1M
Net Income
-$1M
EPS (Diluted)
$-0.12
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$698
Free Cash Flow
-$5,698
Stock-Based Comp.
$429
Balance Sheet
Total Assets
$6M
Total Liabilities
$8M
Stockholders' Equity
-$2M
Cash & Equivalents
$6M
← FY 2020
All Quarters
Q3 2020 →